Free Trial
LON:SBTX

SkinBioTherapeutics (SBTX) Share Price, News & Analysis

SkinBioTherapeutics logo
GBX 16.60 +0.10 (+0.60%)
As of 09:50 AM Eastern

About SkinBioTherapeutics Stock (LON:SBTX)

Key Stats

Today's Range
16.48
17
50-Day Range
16
20.50
52-Week Range
8.50
27.50
Volume
1.32 million shs
Average Volume
1.30 million shs
Market Capitalization
£37.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SBTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SkinBioTherapeutics and its competitors with MarketBeat's FREE daily newsletter.

SBTX Stock News Headlines

This Could Be the Most Profitable Season of Your Life
Institutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the same point in every cycle when crypto enters its most explosive phase — and two experts are showing how to ride it. Inside The Crypto Code Workshop, you’ll get their step-by-step system and $10 in free Bitcoin for attending.
SkinBioTherapeutics Expands in Skin Health Market
See More Headlines

SBTX Stock Analysis - Frequently Asked Questions

SkinBioTherapeutics' stock was trading at GBX 18.49 at the beginning of the year. Since then, SBTX stock has decreased by 10.2% and is now trading at GBX 16.60.

SkinBioTherapeutics plc (LON:SBTX) announced its quarterly earnings data on Wednesday, March, 26th. The company reported ($0.46) earnings per share (EPS) for the quarter. SkinBioTherapeutics had a negative net margin of 237.95% and a negative trailing twelve-month return on equity of 115.86%.

Shares of SBTX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that SkinBioTherapeutics investors own include OptiBiotix Health (OPTI), Ecora Resources (ECOR), Avacta Group (AVCT), Inspired (INSE), Lb-shell (LBP), Anglo African Oil & Gas (AAOG) and Avino Silver & Gold Mines (ASM).

Company Calendar

Last Earnings
3/26/2025
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:SBTX
CIK
N/A
Fax
N/A
Employees
11
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (1.63)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£3.71 million
Net Margins
-237.95%
Pretax Margin
N/A
Return on Equity
-115.86%
Return on Assets
-61.18%

Debt

Debt-to-Equity Ratio
27.57
Current Ratio
0.93
Quick Ratio
10.01

Sales & Book Value

Annual Sales
£1.56 million
Price / Sales
24.29
Cash Flow
GBX 1.84 per share
Price / Cash Flow
9.00
Book Value
GBX 1.68 per share
Price / Book
9.89

Miscellaneous

Outstanding Shares
228,436,000
Free Float
N/A
Market Cap
£37.92 million
Optionable
Not Optionable
Beta
2.01
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (LON:SBTX) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners